Results 101 to 110 of about 3,221,536 (372)
The property of gelatine to coagulate blood is specified in 1896 by Dastre and Floresco. The resulting gelatinous blood coagulation is able to organize itself quickly. The author, together with Cornil, experienced the nutritious and absorbent properties of gelatine and other protein substances (by marking pieces of sponge wetted in these substances, in
openaire +3 more sources
Anesthesia for cystotomy in a dog with pancreatitis and a portosystemic shunt [PDF]
A 21-month-old Cocker spaniel with a portosystemic shunt, a moderate thrombocytopenia and a history of pancreatitis, was anesthetized for a cystotomy to remove bladder polyps and stones.
Brearley, JC+3 more
core +1 more source
Bleeding‐Mimetic Damage‐Detecting and Self‐Healing Modular Skin for Inflatable Structures
A damage‐detecting and self‐healing system inspired by the human bleeding mechanism is developed for inflatable structures, using a liquid conductive elastomeric material enclosed in a small pouch. This material, composed of uncured elastomer, its curing agent, conductive particles, and a dispersant, solidifies only after being exposed to air and ...
Hyun Jae Lee, Ryuma Niiyama
wiley +1 more source
Effectiveness of 4 Pulpotomy Techniques—Randomized Controlled Trial [PDF]
Pulpotomy is the accepted therapy for the management of cariously exposed pulps in symptom-free primary molars; however, evidence is lacking about the most appropriate technique.
Crispin, A.+6 more
core +1 more source
A highly efficient extracorporeal device for treating bacteremia is developed by integrating microfluidic bacterial margination and engineered cell‐depleted thrombi strategically constructed in the device. The rodent models, severely infected with antibiotic‐resistant bacteria, recover from bacteremia after two subsequent extracorporeal blood ...
Bong Hwan Jang+4 more
wiley +1 more source
Clinical studies on topical hemostat Avitene in urological surgery [PDF]
Avitene (Microfibrillar Collagen Hemostat) is a new absorbable topical hemostatic agent, of which action mechanisms are platelet entrapment and activation of platelet clotting factors.
久保, 星一, 小柴, 健, 石橋, 晃
core
This work reports a mitochondria‐targeted nanozyme platform, MIL‐Cu1.8S‐TPP/FA, which induces potent cuproptosis via localized delivery of Cu1.8S nanodots to mitochondria. Surface‐anchoring these nanodots onto MIL‐88B metal‐organic frameworks enhances both passive and active tumor targeting.
Chenguang Liu+8 more
wiley +1 more source
Hemostatic Agents in Critically Ill Patients
How to cite this article: Das SK, Reddy MM, Ray S. Hemostatic Agents in Critically Ill Patients. Indian J Crit Care Med 2019;23(Suppl 3):S226-S229.
Saurabh Kumar Das+2 more
openaire +3 more sources
Optimizing Hemostatic Practices: Matching the Appropriate Hemostat to the Clinical Situation [PDF]
Achieving hemostasis is a critical focus of clinicians working in the surgical setting, given that uncontrolled surgical bleeding is associated with increased mortality rates and higher costs of care.
Neveleff, Deborah J.
core +1 more source
Advanced Pharmaceutical Nanotechnologies Applied for Chinese Herbal Medicines
This review offers a comprehensive overview of pharmaceutical nanotechnology strategies to address limitations associated with the complex material basis and relative mild therapeutic efficacy of Chinese herbal medicines, and summarizes the advantages of these strategies.
Jiameng Li+11 more
wiley +1 more source